Brief: Observe Medical H2 Net Finance Loss Widens To NOK 11.2 Mln

Observe Medical ASA

19/03/2025 06:47

March 19 (Reuters) - Observe Medical ASA OBSRV.OL:

SAID ON TUESDAY H2 2024 OPERATING REVENUES NOK 5.4 MLN, DECREASE OF NOK -10.7 MLN YOY

H2 EBITDA ADJUSTED FOR SPECIAL ITEMS NEGATIVE NOK 14.3 MLN, IMPROVED BY NOK 2.3 MLN YOY

H2 NET FINANCE RESULT NEGATIVE NOK 11.2 MLN VS. NEGATIVE NOK 5.1 MLN YR AGO

LOWER RESULT IS MAINLY DRIVEN BY WRITE-DOWN OF GOODWILL IN H2 OF NOK -69.8 MLN

DESPITE RAISING NOK 22.9 MLN IN GROSS PROCEEDS, FURTHER FUNDING IS NECESSARY TO SUPPORT PRODUCT DEVELOPMENT, PRODUCTION, SALES

CO DOES NOT HAVE SUFFICIENT WORKING CAPITAL FOR NEXT 12 MONTHS, THERE IS MATERIAL UNCERTAINTY REGARDING ITS ONGOING FUNDING

IF REQUIRED CAPITAL IS NOT SECURED, CO MAY STRUGGLE TO MEET LIABILITIES IN 2025

 Source text for Workspace: nWkr8xwkNV
 Further company coverage: OBSRV.OL

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))